AptarGroup, Inc. $ATR Shares Bought by Franklin Resources Inc.

Franklin Resources Inc. grew its position in AptarGroup, Inc. (NYSE:ATR) by 9.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 25,445 shares of the industrial products company’s stock after acquiring an additional 2,212 shares during the period. Franklin Resources Inc.’s holdings in AptarGroup were worth $3,980,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Avantax Advisory Services Inc. increased its position in AptarGroup by 18.2% during the 1st quarter. Avantax Advisory Services Inc. now owns 2,256 shares of the industrial products company’s stock worth $335,000 after purchasing an additional 348 shares during the period. LPL Financial LLC boosted its stake in shares of AptarGroup by 10.4% in the first quarter. LPL Financial LLC now owns 47,234 shares of the industrial products company’s stock valued at $6,794,000 after buying an additional 4,451 shares in the last quarter. Argent Trust Co grew its holdings in AptarGroup by 29.6% during the first quarter. Argent Trust Co now owns 2,835 shares of the industrial products company’s stock worth $421,000 after acquiring an additional 648 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in AptarGroup by 0.9% during the first quarter. Charles Schwab Investment Management Inc. now owns 422,604 shares of the industrial products company’s stock worth $62,706,000 after acquiring an additional 3,867 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. raised its position in AptarGroup by 1.4% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 14,944 shares of the industrial products company’s stock worth $2,217,000 after acquiring an additional 202 shares in the last quarter. 88.52% of the stock is owned by hedge funds and other institutional investors.

AptarGroup Stock Performance

Shares of ATR opened at $123.24 on Tuesday. AptarGroup, Inc. has a 12-month low of $103.23 and a 12-month high of $174.10. The stock has a market cap of $8.09 billion, a P/E ratio of 21.21, a PEG ratio of 2.55 and a beta of 0.55. The company has a current ratio of 1.21, a quick ratio of 0.83 and a debt-to-equity ratio of 0.20. The company has a 50-day moving average of $125.41 and a two-hundred day moving average of $140.66.

AptarGroup (NYSE:ATR) last issued its quarterly earnings data on Thursday, October 30th. The industrial products company reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.05. AptarGroup had a net margin of 10.84% and a return on equity of 15.39%. The business had revenue of $961.13 million during the quarter, compared to analysts’ expectations of $950.55 million. During the same period last year, the company posted $1.49 EPS. The company’s revenue was up 5.7% on a year-over-year basis. AptarGroup has set its Q4 2025 guidance at 1.200-1.28 EPS. As a group, research analysts predict that AptarGroup, Inc. will post 5.57 EPS for the current fiscal year.

AptarGroup Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, November 13th. Stockholders of record on Thursday, October 23rd were issued a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a dividend yield of 1.6%. This is a positive change from AptarGroup’s previous quarterly dividend of $0.45. The ex-dividend date of this dividend was Thursday, October 23rd. AptarGroup’s payout ratio is presently 30.72%.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Wells Fargo & Company decreased their target price on shares of AptarGroup from $152.00 to $133.00 and set an “overweight” rating on the stock in a research report on Monday, November 3rd. Robert W. Baird decreased their price objective on shares of AptarGroup from $160.00 to $145.00 and set an “outperform” rating on the stock in a report on Monday, November 3rd. Raymond James Financial restated an “outperform” rating and set a $172.00 target price (down from $182.00) on shares of AptarGroup in a research report on Monday, August 4th. William Blair downgraded shares of AptarGroup from an “outperform” rating to a “market perform” rating in a research report on Monday, November 3rd. Finally, Zacks Research lowered AptarGroup from a “hold” rating to a “strong sell” rating in a research note on Friday, November 14th. Four investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $168.60.

Insider Buying and Selling at AptarGroup

In related news, insider Shiela Vinczeller sold 1,167 shares of the stock in a transaction on Friday, September 5th. The stock was sold at an average price of $137.97, for a total transaction of $161,010.99. Following the sale, the insider owned 25,134 shares of the company’s stock, valued at $3,467,737.98. This trade represents a 4.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Gael Touya sold 2,500 shares of AptarGroup stock in a transaction dated Thursday, September 11th. The stock was sold at an average price of $136.12, for a total value of $340,300.00. Following the sale, the insider owned 31,463 shares of the company’s stock, valued at approximately $4,282,743.56. This represents a 7.36% decrease in their position. The SEC filing for this sale provides additional information. 0.68% of the stock is owned by corporate insiders.

About AptarGroup

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.